Doherty Catherine T.'s Form 4 filing
Quest Diagnostics Inc (DGX) · filed Mar 5, 2025
- Accession no.
- 0001022079-25-000091
- Filed
- Mar 5, 2025
- Trade date
- Mar 3-4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $125.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Doherty Catherine T.CIK 0001520897 | Officer (EVP, Regional Businesses) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | FTax withholdingDisposed | −394 | $173.74 | −$68,453.56 | 68,784 | Direct | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −716 | $175.79 | −$125,865.64 | 68,068 | Direct | |
| Mar 4, 2025 | Common Stock | AGrant or awardAcquired | +10,380 | $173.74 | +$1,803,421.2 | 78,448 | Direct | |
| Mar 4, 2025 | Common Stock | FTax withholdingDisposed | −5,010 | $173.74 | −$870,437.4 | 73,438 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.